This HTML5 document contains 11 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n2http://ns.inria.fr/covid19/ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83#
dcthttp://purl.org/dc/terms/
fabiohttp://purl.org/spar/fabio/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
frbrhttp://purl.org/vocab/frbr/core#
covidhttp://ns.inria.fr/covid19/
xsdhhttp://www.w3.org/2001/XMLSchema#
Subject Item
n2:abstract
rdf:type
fabio:Abstract
rdf:value
BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) was an emerging hemorrhagic fever that was caused by a tick-borne bunyavirus, SFTSV. Although SFTSV nonstructural protein can inhibit type I interferon (IFN-I) production Ex Vivo and IFN-I played key role in resistance SFTSV infection in animal model, the role of IFN-I in patients is not investigated. METHODS: We have assayed the concentration of IFN-α, a subtype of IFN-I as well as other cytokines in the sera of SFTS patients and the healthy population with CBA (Cytometric bead array) assay. RESULTS: The results showed that IFN-α, tumor necrosis factor (TNF-α), granulocyte colony-stimulating factor (G-CSF), interferon-γ (IFN-γ), macrophage inflammatory protein (MIP-1α), interleukin-6 (IL-6), IL-10, interferon-inducible protein (IP-10), monocyte chemoattractant protein (MCP-1) were significantly higher in SFTS patients than in healthy persons (p < 0.05); the concentrations of IFN-α, IFN-γ, G-CSF, MIP-1α, IL-6, and IP-10 were significant higher in severe SFTS patients than in mild SFTS patients (p < 0.05). CONCLUSION: The concentration of IFN-α as well as other cytokines (IFN-γ, G-CSF, MIP-1α, IL-6, and IP-10) is correlated with the severity of SFTS, suggesting that type I interferon may not be significant in resistance SFTSV infection in humans and it may play an import role in cytokine storm.
dct:subject
Zoonoses Arthropod-borne viral fevers and viral haemorrhagic fevers Antivirals Cytokines Insect-borne diseases Tick-borne diseases Immunostimulants Phleboviruses
frbr:partOf
covid:ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83